Does APREPITANT Cause Off label use? 651 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 651 reports of Off label use have been filed in association with APREPITANT (CINVANTI). This represents 11.6% of all adverse event reports for APREPITANT.
651
Reports of Off label use with APREPITANT
11.6%
of all APREPITANT reports
295
Deaths
526
Hospitalizations
How Dangerous Is Off label use From APREPITANT?
Of the 651 reports, 295 (45.3%) resulted in death, 526 (80.8%) required hospitalization, and 349 (53.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 651 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which APREPITANT Alternatives Have Lower Off label use Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL